Quantcast

BCC Research Publishes a New Report on Global Markets for Pharmaceutical Excipients

October 18, 2013

The global market for pharmaceutical excipients was valued at $5.8 billion in 2012 and is expected to reach $6.3 billion in 2013. BCC Research projects the market to grow to $8.8 billion by 2018, and register a five-year compound annual growth rate (CAGR) of 6.9% from 2013 to 2018.

Wellesley, MA (PRWEB) October 18, 2013

According to a new technical market research report, Excipients in Pharmaceuticals from BCC Research (http://www.bccresearch.com), the global market for pharmaceutical excipients was valued at $5.8 billion in 2012 and is expected to reach $6.3 billion in 2013. BCC Research projects the market to grow to $8.8 billion by 2018, and register a five-year compound annual growth rate (CAGR) of 6.9% from 2013 to 2018.

Pharmaceutical excipients, which serve various therapeutic-enhancing purposes such as facilitating drug absorption or solubility, are now being recognized for their true importance by the pharmaceutical industry and by the world’s regulatory bodies, including the FDA and the European Medicines Agency. Positive trends in the market include the development of creative ideas in response to the need for new excipients, and new levels of cooperation between major players. These forces are influencing the global market for excipients to significant degree. Additionally, the development of novel innovations in response to the need for new excipients is also an important contributor to industry growth.

The significant forces that offer challenges to the global excipients industry in 2013 are problems in the global supply chain, the demands of Quality by Design (QbD) and concerns about drug safety, which are beginning to be addressed by most players in the industry. These forces as well as increases in global usage of pharmaceuticals will continue to shape this market over the next five years.

This report from BCC Research provides an overview of the global market for excipients in pharmaceuticals, including examinations of the effects of a crisis in the global supply chain, the demands of QbD, and concerns about drug safety. It includes an analysis of global market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018.

In addition, this study identifies positive trends in the industry, such as the development of innovative ideas in response to the need for new excipients and new levels of cooperation between major players in the industry, and covers the most important issues surrounding excipients: technological, regulatory, economic, and political. Finally, it takes a look at excipient technology by chemical compounds, functional uses, delivery systems and finished products, and provides comprehensive company profiles of suppliers and others relevant to the industry.

As a market and technology summary, this report consolidates a wide range of industrial and technical information that will aid excipient suppliers, chemical companies, drug manufacturers, healthcare regulators, and congressional staffers keep current with today’s marketplace. The report will be of value to companies interested in entering or expanding their involvement in the field. The report also will provide senior marketing personnel and executive planners with insight about what materials can best satisfy customer demands. In addition, market projections will be of interest to venture capitalists interested in exploring commercialization opportunities, as well as companies and personnel involved in designing and constructing chemical and excipient manufacturing plants and/or those who service such plants.

For the original version on PRWeb visit: http://www.prweb.com/releases/2013/10/prweb11237086.htm


Source: prweb



comments powered by Disqus